Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPEPPS | P55786 | 8/20 | 0.35 |
| ▸ | ANPEP | P15144 | 8/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.34 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | TARS1 | P26639 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29835052 | 0.90 | ADORA2A (0.38) | NPEPPSANPEPADORA2AADORA2BSMN1; SMN2 | |
| SCHEMBL26981136 | 0.90 | ADORA2A (0.38) | NPEPPSANPEPADORA2AADORA2BSMN1; SMN2 | |
| SCHEMBL31406536 | 0.84 | ADORA2A (0.36) | NPEPPSANPEPADORA2AADORA2BSMN1; SMN2 | |
| SCHEMBL28344455 | 0.84 | ADORA2A (0.36) | NPEPPSANPEPADORA2AADORA2BSMN1; SMN2 | |
| SCHEMBL29435121 | 0.81 | TARS1 (0.38) | TARS1TP53LMNAHTT | |
| SCHEMBL16987222 | 0.81 | TARS1 (0.38) | TARS1TP53LMNAHTT | |
| SCHEMBL28564130 | 0.81 | TARS1 (0.38) | TARS1TP53LMNAHTT | |
| SCHEMBL29407144 | 0.81 | KDM4E (0.31) | NPEPPSANPEP | |
| SCHEMBL29043762 | 0.81 | KDM4E (0.31) | NPEPPSANPEP | |
| SCHEMBL30042226 | 0.78 | PI4KA (0.39) | ADORA2AADORA2BADORA3SMN1; SMN2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118949075-A | Treatment of cilia disease | 埃泽瑞斯公司 | 2024-11-15 | — | — | CN | disclosed |